Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythromycin vs Gastric Lavage for Endoscopy Prep in Upper GI Bleeding
NCT00259220Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2005
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of erythromycin in upper gastrointestinal bleeding (UGIB) (3 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Endoscopic yield (visualization of the gastric tract). Started Dec 2005; status: completed.
02
Drugs
erythromycin
03
Conditions
upper gastrointestinal bleeding (UGIB)
Beyond the preview
Go deeper on NCT00259220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00259220.